Get the Stockscreener App
2.12
0.00%
0.00
Repare Therapeutics Inc stock is traded at $2.12, with a volume of 227.94K.
It is up +0.00% in the last 24 hours and up +8.16% over the past month.
Repare Therapeutics Inc is a precision medicine oncology company focused on the development of synthetic lethality-based therapies for patients with cancer. The Company's focus is the research, development and commercialization of precision oncology drugs targeting specific vulnerabilities of tumors in genetically defined patient populations.
See More
Previous Close:
$2.12
Open:
$2.12
24h Volume:
227.94K
Relative Volume:
0.58
Market Cap:
$91.34M
Revenue:
$51.13M
Net Income/Loss:
$-93.80M
P/E Ratio:
-0.9507
EPS:
-2.23
Net Cash Flow:
$-129.10M
1W Performance:
-4.93%
1M Performance:
+8.16%
6M Performance:
+60.61%
1Y Performance:
-30.49%
1-Day Range:
$2.105
$2.15
1-Week Range:
$2.08
$2.25
52-Week Range:
$0.89
$4.0695
Repare Therapeutics Inc Stock (RPTX) Company Profile
Name
Repare Therapeutics Inc
Sector
Industry
Phone
(857) 412-7018
Address
7171 FREDERICK BANTING, SAINT-LAURENT, QC
Compare RPTX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
RPTX
Repare Therapeutics Inc
|
2.125 | 91.13M | 51.13M | -93.80M | -129.10M | -2.23 |
|
VRTX
Vertex Pharmaceuticals Inc
|
428.95 | 107.58B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
782.48 | 80.03B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
430.87 | 57.37B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
907.77 | 55.83B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
207.36 | 44.13B | 447.02M | -1.18B | -906.14M | -6.1812 |
Repare Therapeutics Inc Stock (RPTX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-09-23 | Upgrade | Stifel | Hold → Buy |
| Feb-03-23 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jan-06-23 | Initiated | CapitalOne | Overweight |
| Apr-12-22 | Downgrade | Stifel | Buy → Hold |
| Mar-17-22 | Resumed | Goldman | Buy |
| Sep-23-21 | Initiated | Stifel | Buy |
| Sep-13-21 | Initiated | H.C. Wainwright | Buy |
| Jun-28-21 | Initiated | Guggenheim | Buy |
| Mar-01-21 | Initiated | Berenberg | Buy |
| Oct-28-20 | Initiated | Northland Capital | Outperform |
| Jul-14-20 | Initiated | Cowen | Outperform |
| Jul-14-20 | Initiated | Goldman | Neutral |
| Jul-14-20 | Initiated | Morgan Stanley | Overweight |
| Jul-14-20 | Initiated | Piper Sandler | Overweight |
View All
Repare Therapeutics Inc Stock (RPTX) Latest News
Repare Therapeutics Inc. (NASDAQ:RPTX) Receives Consensus Recommendation of "Hold" from Analysts - MarketBeat
Repare shareholders vote in favor of Xeno bid - The Pharma Letter
Repare Therapeutics Inc. (RPTX) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Repare Therapeutics Enters into Support and Voting Agreements with Significant Shareholders for Proposed Transaction with XenoTherapeutics, Inc. - Investing News Network
Repare signs support agreements with key shareholders for Xenotherapeutics deal - MarketScreener
Repare Therapeutics (RPTX) secures 40% shareholder support for XenoTherapeutics deal - Stock Titan
Why hedge funds are buying Repare Therapeutics Inc. stockJuly 2025 Breakouts & Expert Verified Stock Movement Alerts - newser.com
Repare Therapeutics Reports Positive Q3 2025 Results - TipRanks
Can Repare Therapeutics Inc. stock rebound after recent weaknessQuarterly Investment Review & Weekly Watchlist of Top Performers - newser.com
Repare Therapeutics Inc. stock volume spike explainedJuly 2025 Update & Expert Curated Trade Ideas - newser.com
Why Repare Therapeutics Inc. stock could rally in 2025Index Update & Risk Controlled Swing Trade Alerts - newser.com
Smart tools for monitoring Repare Therapeutics Inc.’s price action2025 Momentum Check & Smart Money Movement Tracker - newser.com
TD Cowen Downgrades Repare Therapeutics (NASDAQ:RPTX) to Hold - MarketBeat
Risk adjusted return profile for Repare Therapeutics Inc. analyzedRisk Management & Technical Pattern Alert System - newser.com
Applying chart zones and confluence areas to Repare Therapeutics Inc.July 2025 Snapshot & Daily Entry Point Alerts - newser.com
Halper Sadeh LLC Encourages RPTX, SEE, CDTX, MRSN Shareholders to Contact the Firm to Discuss Their Rights - The Malaysian Reserve
Candlestick signals on Repare Therapeutics Inc. stock todayJuly 2025 Analyst Calls & Technical Entry and Exit Alerts - newser.com
Stock Traders Purchase High Volume of Call Options on Repare Therapeutics (NASDAQ:RPTX) - MarketBeat
Repare Therapeutics Announces Acquisition by XenoTherapeutics - MSN
Real time scanner hits for Repare Therapeutics Inc. explainedJuly 2025 Highlights & Free Risk Controlled Daily Trade Plans - newser.com
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An - GlobeNewswire
Repare Therapeutics Gains Attention Amid Acquisition Buzz - StocksToTrade
Cambridge-Montreal biotech Repare Therapeutics to be acquired by XenoTherapeutics - The Business Journals
Repare Therapeutics (RPTX) Soars on XenoTherapeutics Takeover Deal: Cash + CVR Offer, Analyst Downgrade and What to Watch on 17 November 2025 - ts2.tech
Repare Therapeutics Agrees To Acquisition As Board Cites Best Path For Stakeholder Value - Benzinga
Repare Therapeutics Unveils Phase 1 LIONS Trial Data - MSN
[8-K] Repare Therapeutics Inc. Reports Material Event | RPTX SEC FilingForm 8-K - Stock Titan
Repare Therapeutics (RPTX) on Acquisition Path: Explained - timothysykes.com
TD Cowen Downgrades Repare Therapeutics to Hold From Buy - MarketScreener
Repare Therapeutics stock rating downgraded to Hold by TD Cowen after acquisition news - Investing.com
Repare +30%, Nuvalent +9% Lead After-Hours Biotech Gains - Nasdaq
Repare Therapeutics to be Acquired by XenoTherapeutics - citybiz
Repare Therapeutics (NASDAQ:RPTX) Upgraded by Wall Street Zen to Hold Rating - MarketBeat
Repare Therapeutics to be Acquired by XenoTherapeutics in Strategic Move - MSN
Repare Therapeutics Inc. (RPTX) Reports Break-Even Earnings for Q3 - MSN
Repare Therapeutics Inc Stock (RPTX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.50%
1.41%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):